As leader of the Life Sciences Strategic Business Unit at A&M, Mr. Schur directs clinical development commercial strategy, medical engagement, and market access capabilities. He brings deep expertise in the pharmaceutical, biotechnology, and medical devices industries, and extensive leadership experience across product launches, due diligence, commercial assessments, and strategic planning. Mr. Schur has experience in medical affairs and market access engagements spanning multiple therapeutic areas, including oncology, hematology, immunology, cardiometabolic diseases, central nervous system/neuroscience, and rare diseases. 

Prior to joining A&M, Mr. Schur most recently served as Partner and Commercial Lead for the Life Sciences Sector within EY’s Business Consulting practice, leading launch strategy, commercial strategy, and market access engagements across therapeutic areas, and advising pharmaceutical and biotechnology clients on commercial assessments, strategic planning, and go-to-market execution plans. He spent nearly 15 years with Navigant Consulting (later Guidehouse) as Global Area Leader of the Life Sciences Strategy Practice and a member of the Healthcare Management Committee.

Prior to his career in management consulting, Mr. Schur held marketing and commercial leadership roles at Bristol-Myers Squibb (BMS) and Johnson & Johnson. During his five years at BMS, as Vice President, Marketing, he led the US Plavix commercial team through the launch of the acute coronary syndrome (ACS) indication and related clinical initiatives; set cardiovascular strategy for BMS and early development compounds including Eliquis; and managed the North American commercial alliance between BMS and Sanofi-Aventis. Prior to that, during his 12 years at Johnson & Johnson, Mr. Schur managed assignments across the US and Brazil, spanning women’s healthcare, Rx-to-OTC switches, anti-infectives, and antifungals.

Mr. Schur earned a bachelor’s degree in marketing and finance and a postgraduate degree in finance from Fundação Getulio Vargas (FGV), Sao Paulo. He serves as an advisor at Rutgers University’s Edward J. Bloustein School of Planning and Public Policy, and has been a member of several nonprofit boards, including the American Heart Association, The Leukemia & Lymphoma Society (LLS), and Susan G. Komen.